Home•Our Research•Publications•Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)

Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)

Thematic Area:
Therapeutics
Disease Area:
EpilepsyRare Neurological Disorders
Research Focus:
Health Data Analytics
Collaborators:
AcademicClinical